MLTX

ABBV ABBV:CA Biotechnology MLTX MRK MRK:CA Terry Chrisomalis Uncategorized

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal

Feb 24, 2026

Biotechnology MLTX Uncategorized

MoonLake nabs FDA Fast Track status for rare inflammatory disorder asset

Feb 2, 2026

moonlake-cut-to-sell-at-goldman-sachs-on-risks-to-lead-asset’s-approval

Biotechnology MLTX Uncategorized

MoonLake cut to sell at Goldman Sachs on risks to lead asset’s approval

Jan 15, 2026

Comment (1) alexsl MoonLake Immunotherapeutics (MLTX) traded lower on Thursday after Goldman Sachs downgraded the...